Literature DB >> 1849773

Influence of lorcainide on microsomal Na+, K(+)-ATPase in guinea-pig isolated heart preparations.

A A Almotrefi1, N Dzimiri.   

Abstract

1. The effects of lorcainide on the myocardial Mg2(+)-dependent, Na+ and K(+)-activated adenosine triphosphatase (Na+, K(+)-ATPase) were compared in guinea-pig heart preparations with those of ouabain, a specific inhibitor of the enzyme activity. 2. Both ouabain and lorcainide inhibited the microsomal Na+, K(+)-ATPase activity in a concentration-dependent fashion. Their inhibitory effective ranges were 0.05-100 microM and 0.15-125 microM, respectively, and the concentrations for half maximal inhibition (IC50 values) were 2.1 +/- 0.3 and 33.5 +/- 7.3 microM, respectively. 3. In a second series of experiments, the combined effects of the two drugs on the enzyme activity were studied. In these experiments, lorcainide produced a concentration-dependent potentiation of the inhibitory effects of ouabain on Na+, K(+)-ATPase activity. 4. The present study demonstrates that lorcainide is a potent inhibitor of myocardial Na+, K(+)-ATPase.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849773      PMCID: PMC1918047          DOI: 10.1111/j.1476-5381.1991.tb12205.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

Review 1.  Antiarrhythmic drugs and the cardiac sodium channel: current models.

Authors:  R S Sheldon; R J Hill; H J Duff
Journal:  Clin Chem       Date:  1989-05       Impact factor: 8.327

Review 2.  The antiarrhythmic properties of beta-adrenoceptor antagonists.

Authors:  A P IJzerman; W Soudijn
Journal:  Trends Pharmacol Sci       Date:  1989-01       Impact factor: 14.819

3.  Chronic lorcainide therapy for symptomatic premature ventricular complexes: efficacy, pharmacokinetics and evidence for norlorcainide antiarrhythmic effect.

Authors:  R H Mead; D L Keefe; R E Kates; R A Winkle
Journal:  Am J Cardiol       Date:  1985-01-01       Impact factor: 2.778

4.  Effect of amiodarone on Na+-, K+-ATPase and Mg2+-ATPase activities in rat brain synaptosomes.

Authors:  K S Prasada Rao; S B Rao; P H Camus; H M Mehendale
Journal:  Cell Biochem Funct       Date:  1986-04       Impact factor: 3.685

5.  A new, sensitive determination of phosphate.

Authors:  H Eibl; W E Lands
Journal:  Anal Biochem       Date:  1969-07       Impact factor: 3.365

6.  Current classification of antiarrhythmic drugs as a guide to their rational clinical use.

Authors:  D C Harrison
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

7.  Influence of derivation on the lipophilicity and inhibitory actions of cardiac glycosides on myocardial Na+-K+-ATPase.

Authors:  N Dzimiri; U Fricke; W Klaus
Journal:  Br J Pharmacol       Date:  1987-05       Impact factor: 8.739

8.  (+)-sotalol causes significant occupation of beta-adrenoceptors at concentrations that prolong cardiac repolarization.

Authors:  J Reid; G Duker; O Almgren; V Nerme
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-03       Impact factor: 3.000

9.  Suggestive evidence for inhibitory action of amiodarone on Na+, K+-pump activity in guinea pig heart.

Authors:  M Aomine
Journal:  Gen Pharmacol       Date:  1989

Review 10.  Recent antiarrhythmic drugs.

Authors:  P Jaillon; M Drici
Journal:  Am J Cardiol       Date:  1989-12-05       Impact factor: 2.778

View more
  1 in total

1.  Variations in potassium concentration modify the inhibitory effect of lorcainide on myocardial Na(+)-K(+)-ATPase activity.

Authors:  A A Almotrefi; N Dzimiri
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.